Prioritising cardiovascular disease risk assessment to high risk individuals based on primary care records
PLoS Medicine,
by Ryan Chung, Zhe Xu, Matthew Arnold, David Stevens, Ruth Keogh, Jessica Barrett, Hannah Harrison, Lisa Pennells, Lois G.
by Ryan Chung, Zhe Xu, Matthew Arnold, David Stevens, Ruth Keogh, Jessica Barrett, Hannah Harrison, Lisa Pennells, Lois G.
Why is the incidence of side effects from statins so low in clinical trials but appear to be so high out in the real world?
Eine Überprüfung von 19 Studien legt nahe Statine sind nur für ein geringes Übermaß an Muskelschmerzsymptomen bei Patienten…
With more than 35 million people taking them, statins are among the most commonly prescribed drugs in the United States, as…